ArticleThe Korean journal of internal medicine2022

The efficacy of EGFR-tyrosine kinase inhibitor in non-small cell lung cancer patients with synchronous brain metastasis: a real-world study.

Jin-Hyuk Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.